ProfileGDS4718 / 200974_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 95% 100% 95% 97% 92% 95% 94% 98% 96% 95% 94% 89% 94% 91% 98% 96% 97% 86% 99% 98% 97% 95% 97% 96% 94% 98% 95% 92% 74% 79% 99% 94% 85% 99% 98% 85% 96% 92% 100% 95% 91% 99% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.103794
GSM549102patient 115, normal, homogenized [OPG study]10.353995
GSM549104patient 119, normal, homogenized [OPG study]14.383100
GSM549108patient 138, normal, homogenized [OPG study]10.10595
GSM549119patient 077, normal, homogenized [OPG study]11.210597
GSM549133patient 032, cancer, homogenized [OPG study]9.558392
GSM549139patient 042, cancer, homogenized [OPG study]10.071495
GSM549099patient 107, normal, homogenized [OPG study]10.067594
GSM549109patient 139, normal, homogenized [OPG study]11.390998
GSM549110patient 046, normal, homogenized [OPG study]10.836396
GSM549114patient 063, normal, homogenized [OPG study]10.398595
GSM549122patient 082, normal, homogenized [OPG study]10.096594
GSM549134patient 033, cancer, homogenized [OPG study]9.0067289
GSM549136patient 036, cancer, homogenized [OPG study]10.052794
GSM549140patient 044, cancer, homogenized [OPG study]9.4004291
GSM549111patient 047, normal, homogenized [OPG study]11.625398
GSM549113patient 057, normal, homogenized [OPG study]10.720296
GSM549132patient 031, cancer, homogenized [OPG study]10.921197
GSM549137patient 038, cancer, homogenized [OPG study]8.5949586
GSM549142patient 047, cancer, homogenized [OPG study]11.856199
GSM549100patient 110, normal, homogenized [OPG study]11.243598
GSM549107patient 135, normal, homogenized [OPG study]11.033597
GSM549115patient 068, normal, homogenized [OPG study]10.584795
GSM549116patient 072, normal, homogenized [OPG study]11.112497
GSM549120patient 078, normal, homogenized [OPG study]10.766996
GSM549131patient 030, cancer, homogenized [OPG study]10.060994
GSM549118patient 074, normal, homogenized [OPG study]11.27298
GSM549129patient 027, cancer, homogenized [OPG study]10.111595
GSM549123patient 088, normal, homogenized [OPG study]9.6850692
GSM549124patient 006, cancer, homogenized [OPG study]7.2201374
GSM549126patient 015, cancer, homogenized [OPG study]7.7624879
GSM549128patient 025, cancer, homogenized [OPG study]13.08899
GSM549103patient 117, normal, homogenized [OPG study]9.9244194
GSM549117patient 073, normal, homogenized [OPG study]8.6073285
GSM549138patient 041, cancer, homogenized [OPG study]12.315299
GSM549141patient 045, cancer, homogenized [OPG study]11.262598
GSM549130patient 028, cancer, homogenized [OPG study]8.3827385
GSM549101patient 111, normal, homogenized [OPG study]10.638296
GSM549105patient 128, normal, homogenized [OPG study]9.5190692
GSM549106patient 134, normal, homogenized [OPG study]14.3381100
GSM549112patient 048, normal, homogenized [OPG study]10.281595
GSM549125patient 011, cancer, homogenized [OPG study]9.2172391
GSM549127patient 024, cancer, homogenized [OPG study]13.084799
GSM549135patient 035, cancer, homogenized [OPG study]9.7046893